17 (65.4 %) of 26 patients in the high TIF CD68 group suffered a local tumor recurrence, whereas 3 (14.3 %) out of 21 patients in the low TIF CD68 group did not show local tumor recurrence (Table 2). This evidence concerns the gene CD68 and neoplasm.